Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis

European Journal of Pharmacology

Volumn 705, Issue 1-3, 2013, Pages 86-95

  Majumder, Syamantak ^a   Piguet, Anne Christine ^b   Dufour, Jean François ^b,c   Chatterjee, Suvro ^a  

^a ANNA UNIVERSITY   (India)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

Angiogenesis; Hepatic stellate cells; Hepatocellular carcinoma; Receptor tyrosine kinase; Sunitinib

Indexed keywords

SUNITINIB;

ANGIOGENESIS; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; AORTA; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CELL TRANSDIFFERENTIATION; CELL VIABILITY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; STELLATE CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; AORTA, THORACIC; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CHICK EMBRYO; COLLAGEN; HEPATIC STELLATE CELLS; HUMANS; INDOLES; NEOVASCULARIZATION, PHYSIOLOGIC; PYRROLES; RATS; RATS, WISTAR; WOUND HEALING;

EID: 84875305909     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.02.026     Document Type: Article

References (47)

1. A. Antonelli-Orlidge, K.B. Saunders, S.R. Smith, and P.A. D'Amore An activated form of transforming growth factor beta is produced by cocultures of EC and pericytes Proc. Nat. Acad. Sci. U.S.A 86 1989 4544 4548
2. A. Armulik, A. Abramsson, and C. Betsholtz Endothelial/pericyte interactions Circ. Res. 97 2005 512 523
3. P. Ausprunk, and J. Folkman Migration and proliferation of EC in preformed and newly formed blood vessels during tumor angiogenesis Microvasc. Res. 14 1977 53 65
4. M.F. Burbridge, and D.C. West Rat aortic ring: 3D model of angiogenesis in vitro Methods Mol. Med. 46 2001 185 204
5. D.J. Crocker, T.M. Murad, and J.C. Green Role of the pericyte in healing: an ultrastructural study Exp. Mol. Pathol. 13 1970 51 65
6. G.G. Di Costanzo, R. Tortora, L. Iodice, A.G. Lanza, F. Lampasi, M.T. Tartaglione, F.P. Picciotto, S. Mattera, and M. De Luca Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice Dig. Liver Dis. 9 2012 788 792
7. V. Djonov, M. Schmid, S.A. Tschanz, and P.H. Burri Intussusceptive angiogenesis: its role in embryonic vascular network formation Circ Res. 18 86(3) 2000 286 292
8. D. Donovan, N.J. Brown, E.T. Bishop, and C.E. Lewis Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo Angiogenesis 4 2 2001 113 121
9. J.F. Dufour, and P. Johnson Liver cancer: from molecular pathogenesis to new therapies: summary of the EASL single topic conference J. Hepatol. 52 2010 296 304
10. Y.X. Feng, T. Wang, Y.Z. Deng, P. Yang, J.J. Li, D.X. Guan, F. Yao, Y.Q. Zhu, Y. Qin, H. Wang, N. Li, M.C. Wu, H.Y. Wang, X.F. Wang, S.Q. Cheng, and D. Xie Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model Hepatology 53 2011 483 492
11. I. Flamme, T. Frolich, and W. Risau Molecular mechanisms of vasculogenesis and embryonic angiogenesis J. Cell. Physiol. 173 1997 206 210
12. A. Geerts, R. Vrijsen, J. Rauterberg, A. Burt, P. Schellinck, and E. Wisse In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion J. Hepatol. 9 1989 59 68
13. T. Gonzalo, L. Beljaars, M. van de Bovenkamp, K. Temming, A.M. van Loenen, C. Reker-Smit, D.K. Meijer, M. Lacombe, F. Opdam, G. Kéri, L. Orfi, K. Poelstra, and R.J. Kok Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells J. Pharmacol. Exp. Ther. 321 2007 856 865
14. F.M. Gu, Q.L. Li, Q. Gao, J.H. Jiang, X.Y. Huang, J.F. Pan, J. Fan, and J. Zhou Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3 World J. Gastroenterol. 14 17(34) 2011 3922 3932
15. A. Horowitz, C.B. Menice, R. Laporte, and K.G. Morgan Mechanisms of smooth muscle contraction Physiol. Rev. 76 1996 967 1003
16. H. Huynh, R.W. Ong, P.Y. Li, S.S. Lee, S. Yang, L.W. Chong, D.A. Luu, C.T. Jong, and I.W. Lam Targeting receptor tyrosine kinase pathways in hepatocellular carcinoma Anticancer Agents Med. Chem. 11 6 2011 560 575
17. S. Joshita, K. Yoshizawa, K. Sano, S. Kobayashi, T. Sekiguchi, S. Morita, A. Kamijo, M. Komatsu, T. Umemura, T. Ichijo, A. Matsumoto, and E. Tanaka A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome Intern. Med. 49 11 2010 991 994
18. D.A. Lee, E. Assoku, and V. Doyle A specific quantitative assay for collagen synthesis by cells seeded in collagen-based biomaterials using sirius red F3B precipitation J. Mater. Sci. Mater. Med. 9 1 1998 47 51
19. J.S. Lee, N.K. Decker, S. Chatterjee, J. Yao, S. Friedman, and V. Shah Mechanisms of nitric oxide interplay with Rho GTPase family members in modulation of actin membrane dynamics in pericytes and fibroblasts Am. J. Pathol. 166 2005 1861 1870
20. C.C. Liang, A.Y. Park, and J.L. Guan In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro Nat. Protoc. 2 2 2007 329 333
21. S. Lindert, L. Wickert, I. Sawitza, E. Wiercinska, A.M. Gressner, S. Dooley, and K. Breitkopf Transdifferentiation-dependent expression of alpha-SMA in HSC does not involve TGF-β pathways leading to coinduction of collagen type I and thrombospondin-2 Matrix Biol. 24 2005 198 207
22. Y. Liu, X.M. Wen, E.L. Lui, S.L. Friedman, W. Cui, N.P. Ho, L. Li, T. Ye, S.T. Fan, and H. Zhang Therapeutic targeting of the PDGF and TGF-β-signaling pathways in HSC by PTK787/ZK22258 Lab. Invest. 89 2009 1152 1160
23. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, A.C. de Oliveira, A. Santoro, J.L. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. Bolondi, T.F. Greten, P.R. Galle, J.F. Seitz, I. Borbath, D. Häussinger, T. Giannaris, M. Shan, M. Moscovici, D. Voliotis, and J. Bruix Sorafenib in advanced hepatocellular carcinoma N. Engl. J. Med. 359 2008 378 390
24. D.S.R. Lockwood, and D.C. Gotley Interaction of tumor with host stroma in hepatocellular carcinoma Integr./Interact. Oncologic Growth Cancer Growth Progression 15 2005 165 176
25. S. Majumder, K.P. Tamilarasan, G.K. Kolluru, A. Muley, C.M. Nair, A. Omanakuttan, K.V. Murty, and S. Chatterjee Activated pericyte attenuates endothelial functions: nitric oxide-cGMP rescues activated pericyte-associated endothelial dysfunctions Biochem. Cell. Biol. 85 2007 709 720
26. S. Majumder, A. Muley, G.K. Kolluru, S. Saurabh, K.P. Tamilarasan, S. Chandrasekhar, H.B. Reddy, S. Purohit, and S. Chatterjee Cadmium reduces nitric oxide production by impairing phosphorylation of endothelial nitric oxide synthase Biochem. Cell. Biol. 86 1 2008 1 10
27. D.A. Mann, and D.E. Smart Transcriptional regulation of HSC activation Gut 50 2002 891 896
28. J. Mann, F. Oakley, F. Akiboye, A. Elsharkawy, A.W. Thorne, and D.A. Mann Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis Cell. Death Differ. 14 2007 275 285
29. M. Mikula, V. Proell, A.N. Fischer, and W. Mikulits Activated HSC induce tumor progression of neoplastic hepatocytes in a TGF-β dependent fashion J. Cell Physiol. 209 2006 560 567
30. S. Nakamura, H. Muro, S. Suzuki, T. Sakaguchi, H. Konno, S. Baba, and A.S. Syed Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma Hepatology 26 1997 407 415
31. A. Niemistö, V. Dunmire, O. Yli-Harja, W. Zhang, and I. Shmulevich Robust quantification of in vitro angiogenesis through image analysis IEEE Trans. Med. Imaging 24 2005 549 553
32. A. Orlidge, and P.A. D'Amore Inhibition of capillary EC growth by pericytes and smooth muscle cells J. Cell Biol. 105 1987 1455 1462
33. M. Parola, G. Robino, F. Marra, M. Pinzani, G. Bellomo, G. Leonarduzzi, P. Chiarugi, S. Camandola, G. Poli, G. Waeg, P. Gentilini, and M.U. Dianzani HNE interacts directly with JNK isoforms in human hepatic stellate cells J. Clin. Invest. 1 102(11) 1998 1942 1950
34. R.E. Perri, D.A. Langer, S. Chatterjee, S.J. Gibbons, J. Gadgil, S. Cao, G. Farrugia, and V. Shah Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in HSC upon activation Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G535 G542
35. M.A. Reidy, D. Standaert, and S.M. Schwartz Inhibition of EC replication after balloon catheter denudation Arteriosclerosis 2 1982 216 220
36. M.A. Reidy, A.W. Clowes, and S.M. Schwartz Endothelial regeneration. V. Inhibition of endothelial regrowth in arteries of rat and rabbit Lab. Invest. 49 1983 569 575
37. Y. Sato, and D.B. Rifkin Inhibition of EC movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture J. Cell Biol. 109 1989 309 315
38. D. Semela, and J.F. Dufour Angiogenesis and hepatocellular carcinoma J. Hepatol. 41 2004 864 880
39. D. Semela, A. Das, D. Langer, N. Kang, E. Leof, and V. Shah Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function Gastroenterology 135 2 2008 671 679
40. J.H. Siamwala, S.H. Reddy, S. Majumder, G.K. Kolluru, A. Muley, S. Sinha, and S. Chatterjee Simulated microgravity perturbs actin polymerization to promote nitric oxide-associated migration in human immortalized Eahy926 cells Protoplasma 242 1-4 2010 3 12
41. S. Sinha, S.R. Sridhara, S. Srinivasan, A. Muley, S. Majumder, M. Kuppusamy, R. Gupta, and S. Chatterjee NO (nitric oxide): the ring master Eur. J. Cell. Biol. 90 1 2011 58 71
42. G.A. Soff, T.L. Cornwell, D.L. Cundiff, S. Gately, and T.M. Lincoln Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP J. Clin. Invest. 100 1997 2580 2587
43. G. Srinivas, R.J. Anto, P. Srinivas, S. Vidhyalakshmi, V.P. Senan, and D. Karunagaran Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9 Eur. J. Pharmacol. 473 2003 117 125
44. D. Thabut, C. Routray, G. Lomberk, U. Shergill, K. Glaser, R. Huebert, L. Patel, T. Masyuk, B. Blechacz, A. Vercnocke, E. Ritman, R. Ehman, R. Urrutia, and V. Shah Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis Hepatology 54 2 2011 573 585
45. S. Tugues, G. Fernandez-Varo, J. Muñoz-Luque, J. Ros, V. Arroyo, J. Rodés, S.L. Friedman, P. Carmeliet, W. Jiménez, and M. Morales-Ruiz Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats Hepatology 46 2007 1919 1926
46. H.Y. Woo, J. Heo, K.T. Yoon, G.H. Kim, D.H. Kang, G.A. Song, and M. Cho Clinical course of sorafenib treatment in patients with hepatocellular carcinoma Scand. J. Gastroenterol. 47 7 2012 809 819
47. L. Xu, A.Y. Hui, E. Albanis, M.J. Arthur, S.M. O'Byrne, W.S. Blaner, P. Mukherjee, S.L. Friedman, and F.J. Eng Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis Gut 54 1 2005 142 151